HomeNewsBusinessMarketsFocus should be on IT, pharma, private banks and high-quality midcaps; Look at these top bets
Trending Topics

Focus should be on IT, pharma, private banks and high-quality midcaps; Look at these top bets

We suggest investors to focus on consumer discretionary, IT, private banks and pharma and high quality midcaps for which prices have become cheaper after the consolidation in the last six months, says Vinod Nair of Geojit Financial Services.

August 02, 2018 / 12:23 IST
Story continues below Advertisement

Vinod Nair Geojit Financial Services

Market is heading higher with minor gains on a weekly basis, led by good Q1 results, but at the same time, market is also concerned about the risk-off trend in the domestic & global market. This trend can continue in the near term as risk-taking ability has reduced led by increase in cost of funds, premium valuation and lack of earnings growth compared to high expectations.

Given the headwinds, strength of the market has narrowed within which positive momentum is segregated to super large blue-chips. This positivity can get wider as earnings growth return. There are opportunity for retail investors to look at high quality stocks available at fair valuation with positive outlook. Some of the prices and valuation have become very attractive in the long-term.

Story continues below Advertisement

During the year, main indexes (Nifty50) may be positive but it is limited to the 15 stocks whereas rest of the stocks corrected by an average of -15 percent. At the same time if we look at the broad market, mid & small caps are down by more than 20 percent.

In a nutshell, wealth of the domestic investors has reduced, subject to their exposure in large and defensive stocks. Sectors which have done well includes consumer discretionary, IT, private banks and pharma.